Vaccine Protocols

Editors:

ISBN: 978-1-58829-140-0 (Print) 978-1-59259-399-6 (Online)

Table of contents (24 protocols)

previous Page of 2
  1. Front Matter

    Pages i-xi

  2. Book Protocol

    Pages 1-17

    Overview of Vaccines

  3. No Access

    Book Protocol

    Pages 19-36

    Temperature-Sensitive Mutant Vaccines

  4. No Access

    Book Protocol

    Pages 37-49

    Live Viral Vectors

  5. No Access

    Book Protocol

    Pages 51-68

    Live Viral Vectors

  6. No Access

    Book Protocol

    Pages 69-81

    Live Viral Vectors

  7. No Access

    Book Protocol

    Pages 83-100

    Development of Attenuated Salmonella Strains That Express Heterologous Antigens

  8. No Access

    Book Protocol

    Pages 101-114

    Expression and Delivery of Heterologous Antigens Using Lactic Acid Bacteria

  9. No Access

    Book Protocol

    Pages 115-131

    Synthetic Peptides

  10. No Access

    Book Protocol

    Pages 133-151

    Genetic Detoxification of Bacterial Toxins

  11. No Access

    Book Protocol

    Pages 153-173

    Preparation of Polysaccharide-Conjugate Vaccines

  12. Book Protocol

    Pages 175-193

    Adjuvant Formulations for Experimental Vaccines

  13. No Access

    Book Protocol

    Pages 195-210

    Incorporation of Immunomodulators into Plasmid DNA Vaccines

  14. No Access

    Book Protocol

    Pages 211-222

    Microencapsulation of Vaccine Antigens

  15. No Access

    Book Protocol

    Pages 223-243

    Lyophilization of Vaccines

  16. No Access

    Book Protocol

    Pages 245-253

    Stimulation of Mucosal Immunity

  17. No Access

    Book Protocol

    Pages 255-277

    Induction and Detection of T-Cell Responses

  18. No Access

    Book Protocol

    Pages 279-287

    Construction of MHC Class I-Peptide Tetrameric Complexes for Analysis of T-Cell-Mediated Immune Responses

  19. No Access

    Book Protocol

    Pages 289-300

    Assessment of Functional Antibody Responses

  20. No Access

    Book Protocol

    Pages 301-312

    The Use of Complete Genome Sequences in Vaccine Design

  21. Book Protocol

    Pages 313-334

    Severe Combined Immunodeficient (SCID) Mice in Vaccine Assessment

previous Page of 2